Free Trial
NASDAQ:AFIB

Acutus Medical 8/7/2023 Earnings Report

Acutus Medical logo
$0.04 +0.01 (+21.25%)
As of 05/2/2025 11:34 AM Eastern

Acutus Medical EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.61
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Acutus Medical Revenue Results

Actual Revenue
$5.29 million
Expected Revenue
$4.60 million
Beat/Miss
Beat by +$690.00 thousand
YoY Revenue Growth
N/A

Acutus Medical Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Acutus Medical Earnings Headlines

Acutus Medical Announces Operational Downsizing
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Acutus Medical Reports Q3 2024 Financial Results
See More Acutus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Acutus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acutus Medical and other key companies, straight to your email.

About Acutus Medical

Acutus Medical (NASDAQ:AFIB) designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

View Acutus Medical Profile

More Earnings Resources from MarketBeat